AUG 10, 2016 12:00 PM PDT

TSRI and NIH Scientists Show Molecule in Brain May Drive Cocaine Addiction

LA JOLLA, CA – August 10, 2016 – A new study from scientists at The Scripps Research Institute (TSRI), funded by the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA), suggests that increased levels of a molecule in the brain, called hypocretin, may contribute to cocaine addiction.
 

The research, published recently online ahead of print in the journal Biological Psychiatry, shows that blocking hypocretin may reduce compulsive drug-seeking behavior in rat models of cocaine addiction.

“Cocaine addiction is a disorder that affects millions of people worldwide,” said Marisa Roberto, professor in TSRI’s Committee on the Neurobiology of Addictive Disorders (CNAD) and co-author of the study with Brooke Schmeichel, a former TSRI researcher now at NIDA, George Koob, the CNAD chairman currently on a leave of absence to direct the NIAAA, and Melissa Herman, a senior research associate at TSRI. “Understanding the mechanisms underlying cocaine addiction is important for identifying potential new targets for therapeutic use.”

“The results of this study would suggest that the hypocretin system could be considered a pharmacological target, with the hopes that such a medication could be used in combination with cognitive behavioral therapies,” added Schmeichel.
 

What Fuels Addiction?


Addiction seems like a simple concept—taking a drug motivates a person to continue to take that drug.

But the molecular mechanisms in the brain that drive addiction are more complex. To design treatments for addiction and relapse, scientists need to understand what motivates a person to transition from occasional drug use to compulsive drug use.

In the new study, the researchers, led by Schmeichel, focused on changes in the central amygdala, a brain region associated with stress and negative emotions during drug withdrawal.

Their goal was to better understand the role of a neurotransmitter called hypocretin in the central amygdala. Hypocretin is a main player in the brain’s hypothalamic hypocretin/orexin (HCRT) system, a network that sends signals between brain regions and has been shown to influence the brain’s reactions to cocaine, nicotine, alcohol and opioids and the desire to relapse. Until now, however, scientists did not fully understand the HCRT’s role in cocaine addiction.

For the study, one group of rats was given the option to self-administer cocaine for one hour a day, mimicking conditions of short-term, occasional drug use. A second group had the option to self-administer cocaine for six hours a day, which mimicked the conditions that lead to compulsive drug use and addiction.

The researchers found that compulsive cocaine use triggers a dangerous cycle in the brain, with cocaine sensitizing the HCRT system, which motivates further drug-seeking.

Specifically, compulsive cocaine use leads to increased hypocretin, which contributes to overactivity in the central amygdala. This overactivity corresponds with an anxiety-like state in rat models that appears to help maintain the motivation to continue to seek the drug.

“The rats escalate their daily intake as many human users would,” said Roberto.

Interestingly, giving the rats an “antagonist” to block HCRT activity at one of the two HCRT receptors in the central amygdala helped reduce their drug-seeking behavior, suggesting a potential role for these compounds in treatments for addiction and relapse.

The study was titled “Hypocretin Neurotransmission within the Central Amygdala Mediates Escalated Cocaine Self-Administration and Stress-induced Reinstatement in Rats.” 

The research was supported by the NIH’s National Institute on Drug Abuse (grant DA004043 and DA004398), NIAAA (grant AA007456, AA023002, AA006420 and AA021491) and by the Pearson Center for Alcohol and Addiction Research.

This article was originally published on scripps.edu.
About the Author
  • The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 2,700 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists-including two Nobel laureates-work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.
You May Also Like
AUG 30, 2020
Cell & Molecular Biology
Transfer RNA Mutations May Be an Overlooked Cause of Disease
AUG 30, 2020
Transfer RNA Mutations May Be an Overlooked Cause of Disease
Our bodies need vast numbers of proteins to function. Dysfunctional proteins, which can be caused by errors in the genes ...
SEP 16, 2020
Neuroscience
Men and Women Have Different Circadian Rhythms
SEP 16, 2020
Men and Women Have Different Circadian Rhythms
From a meta-analysis, researchers from the University of Pennsylvania have found that men and women tend to have differe ...
SEP 24, 2020
Health & Medicine
Extreme Isolation can Cause Physical Brain Changes
SEP 24, 2020
Extreme Isolation can Cause Physical Brain Changes
By this point in the year, you’ve either heard or uttered the phrase “quarantine brain.” While the act ...
OCT 05, 2020
Drug Discovery & Development
Fecal Transplants Could Restore Cognitive Function in the Elderly
OCT 05, 2020
Fecal Transplants Could Restore Cognitive Function in the Elderly
An international team of researchers has found that fecal transplants could one day be used to restore cognitive functio ...
OCT 07, 2020
Neuroscience
Biocompatible Gel Restores Sciatic Nerve Function in Rats
OCT 07, 2020
Biocompatible Gel Restores Sciatic Nerve Function in Rats
Video: Explains poly(lactic-co-glycolic acid), a hydrogel biopolymer that is a similar concept to the new hydrogel built ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
Loading Comments...